7 alpha-hydroxy-4-cholesten-3-one has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, Y; Haba, M; Shimada, M; Shinozawa, E; Tozawa, R; Yamakawa, H | 1 |
| DePaoli, AM; Elliott, M; Ko, B; Learned, RM; Lindhout, DA; Ling, L; Luo, J; Phung, V; Tian, H; To, C; Zhou, M | 1 |
| Björkhem, I; Hansson, M | 1 |
1 review(s) available for 7 alpha-hydroxy-4-cholesten-3-one and Disease Models, Animal
| Article | Year |
|---|---|
Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge.
Topics: Animals; Bile Acids and Salts; Cholestanetriol 26-Monooxygenase; Cholestanol; Cholestenones; Cholesterol 7-alpha-Hydroxylase; Disease Models, Animal; Mice; Mutation; Xanthomatosis, Cerebrotendinous | 2010 |
1 trial(s) available for 7 alpha-hydroxy-4-cholesten-3-one and Disease Models, Animal
| Article | Year |
|---|---|
A nontumorigenic variant of FGF19 treats cholestatic liver diseases.
Topics: Adult; Animals; Australia; Bile Acids and Salts; Biomarkers; Cholagogues and Choleretics; Cholestasis, Extrahepatic; Cholestasis, Intrahepatic; Cholestenones; Cholesterol 7-alpha-Hydroxylase; Disease Models, Animal; Double-Blind Method; Down-Regulation; Fibroblast Growth Factors; Gene Expression Regulation, Enzymologic; Gene Transfer Techniques; Genetic Variation; Healthy Volunteers; Humans; Liver; Liver Neoplasms; Male; Mice; Middle Aged; Recombinant Proteins; Risk Assessment; RNA, Messenger; Young Adult | 2014 |
1 other study(ies) available for 7 alpha-hydroxy-4-cholesten-3-one and Disease Models, Animal
| Article | Year |
|---|---|
Antidyslipidemic potential of a novel farnesoid X receptor antagonist in a hamster model of dyslipidemia: Comparative studies of other nonstatin agents.
Topics: Animals; Apolipoprotein A-I; Benzoates; Bile Acids and Salts; Cell Line, Tumor; Cholestenones; Cholesterol; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Dyslipidemias; Feces; Humans; Hypolipidemic Agents; Lipid Metabolism; Male; Mesocricetus; Piperidines; Receptors, Cytoplasmic and Nuclear; Triglycerides | 2018 |